1. The Guardian Connect system uses predictive analytics and artificial intelligence technology from IBM Watson Health to analyze glucose levels.
2. Adcetris is the first new frontline treatment for advanced Hodgkin lymphoma in 40 years.
3. Lucentis is available as a 0.3 milligram prefilled syringe to treat diabetic macular edema and diabetic retinopathy.
4. Hizentra is the first subcutaneous immunoglobulin approved to treat chronic inflammatory demyelinating polyneuropathy, a rare autoimmune disorder that affects the peripheral nerves.
More articles on supply chain:
US grants Amazon patent for drones that react to human gestures
California issues cease-and-desist order to subsidiary of AmerisourceBergen: 6 things to know
FDA approves first frontline treatment for advanced Hodgkin lymphoma in 40 years
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
